WMT

114.55

+1.25%↑

COST

925.26

+1.08%↑

TGT

105.58

-0.61%↓

59.51

-0.45%↓

DG.US

142.85

-0.76%↓

WMT

114.55

+1.25%↑

COST

925.26

+1.08%↑

TGT

105.58

-0.61%↓

59.51

-0.45%↓

DG.US

142.85

-0.76%↓

WMT

114.55

+1.25%↑

COST

925.26

+1.08%↑

TGT

105.58

-0.61%↓

59.51

-0.45%↓

DG.US

142.85

-0.76%↓

WMT

114.55

+1.25%↑

COST

925.26

+1.08%↑

TGT

105.58

-0.61%↓

59.51

-0.45%↓

DG.US

142.85

-0.76%↓

WMT

114.55

+1.25%↑

COST

925.26

+1.08%↑

TGT

105.58

-0.61%↓

59.51

-0.45%↓

DG.US

142.85

-0.76%↓

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

7.51 -2.85

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

7.51

Max

7.58

Schlüsselkennzahlen
By Trading Economics
Einkommen	-7.9M -10M
Verkäufe	-5.3M 31M
Gewinnspanne	-32.116
Angestellte	406

Dividenden
By Dow Jones
Nächstes Ergebnis	16. Jan. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	9.4M 250M
Vorheriger Eröffnungskurs	10.36
Vorheriger Schlusskurs	7.51

Nachrichtenstimmung

By Acuity

20%

80%

11 / 147 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

9. Jan. 2026, 22:18 UTC

Market Talk

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

9. Jan. 2026, 21:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

9. Jan. 2026, 21:50 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Basic Materials Roundup: Market Talk

9. Jan. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

9. Jan. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9. Jan. 2026, 21:43 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

9. Jan. 2026, 20:39 UTC

Market Talk

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

9. Jan. 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

9. Jan. 2026, 20:36 UTC

Akquisitionen, Fusionen, Übernahmen

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

9. Jan. 2026, 20:30 UTC

Market Talk

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

9. Jan. 2026, 20:15 UTC

Market Talk

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

9. Jan. 2026, 20:07 UTC

Market Talk

Global Equities Roundup: Market Talk

9. Jan. 2026, 20:07 UTC

Market Talk

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

9. Jan. 2026, 19:58 UTC

Akquisitionen, Fusionen, Übernahmen

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

9. Jan. 2026, 19:42 UTC

Market Talk

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

9. Jan. 2026, 19:38 UTC

Akquisitionen, Fusionen, Übernahmen

Wolters Kluwer Acquires StandardFusion >WTKWY

9. Jan. 2026, 19:31 UTC

Ergebnisse

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

9. Jan. 2026, 19:28 UTC

Ergebnisse

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

9. Jan. 2026, 18:30 UTC

Market Talk

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

9. Jan. 2026, 18:23 UTC

Market Talk

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

9. Jan. 2026, 17:20 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Basic Materials Roundup: Market Talk

9. Jan. 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

9. Jan. 2026, 17:19 UTC

Market Talk

Energy Prices Not Seen Supporting More Drilling -- Market Talk

9. Jan. 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9. Jan. 2026, 17:07 UTC

Market Talk

McDonald's Promotions Appear Successful -- Market Talk

9. Jan. 2026, 17:06 UTC

Market Talk

Oil Futures on Track for Weekly Gains -- Market Talk

9. Jan. 2026, 17:05 UTC

Ergebnisse

Stocks Sail Past Jobs Data, Tariff Opinion Delay. Earnings Season Looms. -- Barrons.com

9. Jan. 2026, 16:57 UTC

Market Talk

Energy Activity Tumbles in 4Q, KC Fed Survey Finds -- Market Talk

9. Jan. 2026, 16:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9. Jan. 2026, 16:46 UTC

Market Talk

Dollar Could Stay Steady For Now, More Likely to Fall Than Rise -- Market Talk

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Rating-Konsens

By TipRanks

Buy

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Stimmung

By Acuity

11 / 147 Ranking in Konsumgüter defensiv

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.